Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives $10.50 Average Target Price from Analysts

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has received a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are covering the company, Marketbeat reports. Six investment analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $10.50.

Several research firms have recently commented on AVAH. Stephens upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $10.00 to $11.00 in a report on Friday, May 15th. Barclays reduced their price objective on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating on the stock in a report on Monday, May 18th. Raymond James Financial upgraded shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price objective on the stock in a report on Friday, March 20th. Weiss Ratings lowered shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, April 6th. Finally, Zacks Research lowered shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 3rd.

Aveanna Healthcare Stock Up 0.8%

NASDAQ AVAH opened at $7.34 on Friday. Aveanna Healthcare has a 52 week low of $3.73 and a 52 week high of $10.32. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. The business’s fifty day simple moving average is $6.78 and its 200-day simple moving average is $7.81. The firm has a market cap of $1.60 billion, a PE ratio of 6.22, a P/E/G ratio of 0.87 and a beta of 1.93.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The business had revenue of $647.92 million for the quarter, compared to analyst estimates of $613.22 million. The company’s quarterly revenue was up 15.9% on a year-over-year basis. As a group, equities analysts anticipate that Aveanna Healthcare will post 0.56 earnings per share for the current year.

Insider Transactions at Aveanna Healthcare

In related news, insider Patrick A. Cunningham sold 125,000 shares of the business’s stock in a transaction dated Wednesday, May 20th. The shares were sold at an average price of $7.59, for a total value of $948,750.00. Following the sale, the insider directly owned 212,755 shares in the company, valued at approximately $1,614,810.45. The trade was a 37.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 5.30% of the company’s stock.

Institutional Trading of Aveanna Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the stock. AustralianSuper Pty Ltd acquired a new position in Aveanna Healthcare in the 3rd quarter valued at about $15,743,000. Vanguard Group Inc. grew its position in Aveanna Healthcare by 38.0% in the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after acquiring an additional 1,535,351 shares in the last quarter. Millennium Management LLC grew its position in Aveanna Healthcare by 1,007.1% in the 4th quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock valued at $9,107,000 after acquiring an additional 1,014,030 shares in the last quarter. Nuveen LLC grew its position in Aveanna Healthcare by 135.9% in the 4th quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock valued at $12,838,000 after acquiring an additional 905,316 shares in the last quarter. Finally, Hillsdale Investment Management Inc. acquired a new position in Aveanna Healthcare in the 3rd quarter valued at about $7,922,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.